▶ 調査レポート

世界のICU設定における鎮静剤市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Sedation In ICU Setting Market 2021 by Company, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界のICU設定における鎮静剤市場 2021:企業別、地域別、種類・用途別 / Global Sedation In ICU Setting Market 2021 by Company, Regions, Type and Application, Forecast to 2026 / GIR-107A11881資料のイメージです。• レポートコード:GIR-107A11881
• 出版社/出版日:GlobalInfoResearch / 2021年7月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、109ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、ICU設定における鎮静剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ICU設定における鎮静剤の種類別市場規模(プロポフォール、デクスメデトミジン、レミフェンタニル、その他)、用途別市場規模(新生児集中治療室、小児集中治療室、成人集中治療室)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・ICU設定における鎮静剤の市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):AstraZeneca、GlaxoSmithKline、Mylan、Fresenius、Teva、B. Braun Holding、Aspen
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:プロポフォール、デクスメデトミジン、レミフェンタニル、その他
・用途別分析2016年-2026年:新生児集中治療室、小児集中治療室、成人集中治療室
・ICU設定における鎮静剤の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・ICU設定における鎮静剤のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・ICU設定における鎮静剤のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・ICU設定における鎮静剤の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・ICU設定における鎮静剤の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Sedation In ICU Setting market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Sedation In ICU Setting size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Sedation In ICU Setting market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Sedation In ICU Setting market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Propofol
Dexmedetomidine
Remifentanil
Others

Market segment by Application, can be divided into
Neonatal Intensive Care Unit
Child Intensive Care Unit
Adult Intensive Care Unit

Market segment by players, this report covers
AstraZeneca
GlaxoSmithKline
Mylan
Fresenius
Teva
B. Braun Holding
Aspen

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Sedation In ICU Setting
1.2 Classification of Sedation In ICU Setting by Type
1.2.1 Overview: Global Sedation In ICU Setting Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Sedation In ICU Setting Revenue Market Share by Type in 2020
1.2.3 Propofol
1.2.4 Dexmedetomidine
1.2.5 Remifentanil
1.2.6 Others
1.3 Global Sedation In ICU Setting Market by Application
1.3.1 Overview: Global Sedation In ICU Setting Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Neonatal Intensive Care Unit
1.3.3 Child Intensive Care Unit
1.3.4 Adult Intensive Care Unit
1.4 Global Sedation In ICU Setting Market Size & Forecast
1.5 Global Sedation In ICU Setting Market Size and Forecast by Region
1.5.1 Global Sedation In ICU Setting Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Sedation In ICU Setting Market Size by Region, (2016-2021)
1.5.3 North America Sedation In ICU Setting Market Size and Prospect (2016-2026)
1.5.4 Europe Sedation In ICU Setting Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Sedation In ICU Setting Market Size and Prospect (2016-2026)
1.5.6 South America Sedation In ICU Setting Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Sedation In ICU Setting Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Sedation In ICU Setting Market Drivers
1.6.2 Sedation In ICU Setting Market Restraints
1.6.3 Sedation In ICU Setting Trends Analysis
2 Company Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Sedation In ICU Setting Product and Solutions
2.1.4 AstraZeneca Sedation In ICU Setting Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 AstraZeneca Recent Developments and Future Plans
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Sedation In ICU Setting Product and Solutions
2.2.4 GlaxoSmithKline Sedation In ICU Setting Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 GlaxoSmithKline Recent Developments and Future Plans
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Sedation In ICU Setting Product and Solutions
2.3.4 Mylan Sedation In ICU Setting Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Mylan Recent Developments and Future Plans
2.4 Fresenius
2.4.1 Fresenius Details
2.4.2 Fresenius Major Business
2.4.3 Fresenius Sedation In ICU Setting Product and Solutions
2.4.4 Fresenius Sedation In ICU Setting Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Fresenius Recent Developments and Future Plans
2.5 Teva
2.5.1 Teva Details
2.5.2 Teva Major Business
2.5.3 Teva Sedation In ICU Setting Product and Solutions
2.5.4 Teva Sedation In ICU Setting Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Teva Recent Developments and Future Plans
2.6 B. Braun Holding
2.6.1 B. Braun Holding Details
2.6.2 B. Braun Holding Major Business
2.6.3 B. Braun Holding Sedation In ICU Setting Product and Solutions
2.6.4 B. Braun Holding Sedation In ICU Setting Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 B. Braun Holding Recent Developments and Future Plans
2.7 Aspen
2.7.1 Aspen Details
2.7.2 Aspen Major Business
2.7.3 Aspen Sedation In ICU Setting Product and Solutions
2.7.4 Aspen Sedation In ICU Setting Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Aspen Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Sedation In ICU Setting Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Sedation In ICU Setting Players Market Share
3.2.2 Top 10 Sedation In ICU Setting Players Market Share
3.2.3 Market Competition Trend
3.3 Sedation In ICU Setting Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Sedation In ICU Setting Revenue and Market Share by Type (2016-2021)
4.2 Global Sedation In ICU Setting Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Sedation In ICU Setting Revenue Market Share by Application (2016-2021)
5.2 Sedation In ICU Setting Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Sedation In ICU Setting Revenue by Type (2016-2026)
6.2 North America Sedation In ICU Setting Revenue by Application (2016-2026)
6.3 North America Sedation In ICU Setting Market Size by Country
6.3.1 North America Sedation In ICU Setting Revenue by Country (2016-2026)
6.3.2 United States Sedation In ICU Setting Market Size and Forecast (2016-2026)
6.3.3 Canada Sedation In ICU Setting Market Size and Forecast (2016-2026)
6.3.4 Mexico Sedation In ICU Setting Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Sedation In ICU Setting Revenue by Type (2016-2026)
7.2 Europe Sedation In ICU Setting Revenue by Application (2016-2026)
7.3 Europe Sedation In ICU Setting Market Size by Country
7.3.1 Europe Sedation In ICU Setting Revenue by Country (2016-2026)
7.3.2 Germany Sedation In ICU Setting Market Size and Forecast (2016-2026)
7.3.3 France Sedation In ICU Setting Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Sedation In ICU Setting Market Size and Forecast (2016-2026)
7.3.5 Russia Sedation In ICU Setting Market Size and Forecast (2016-2026)
7.3.6 Italy Sedation In ICU Setting Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Sedation In ICU Setting Revenue by Type (2016-2026)
8.2 Asia-Pacific Sedation In ICU Setting Revenue by Application (2016-2026)
8.3 Asia-Pacific Sedation In ICU Setting Market Size by Region
8.3.1 Asia-Pacific Sedation In ICU Setting Revenue by Region (2016-2026)
8.3.2 China Sedation In ICU Setting Market Size and Forecast (2016-2026)
8.3.3 Japan Sedation In ICU Setting Market Size and Forecast (2016-2026)
8.3.4 South Korea Sedation In ICU Setting Market Size and Forecast (2016-2026)
8.3.5 India Sedation In ICU Setting Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Sedation In ICU Setting Market Size and Forecast (2016-2026)
8.3.7 Australia Sedation In ICU Setting Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Sedation In ICU Setting Revenue by Type (2016-2026)
9.2 South America Sedation In ICU Setting Revenue by Application (2016-2026)
9.3 South America Sedation In ICU Setting Market Size by Country
9.3.1 South America Sedation In ICU Setting Revenue by Country (2016-2026)
9.3.2 Brazil Sedation In ICU Setting Market Size and Forecast (2016-2026)
9.3.3 Argentina Sedation In ICU Setting Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Sedation In ICU Setting Revenue by Type (2016-2026)
10.2 Middle East & Africa Sedation In ICU Setting Revenue by Application (2016-2026)
10.3 Middle East & Africa Sedation In ICU Setting Market Size by Country
10.3.1 Middle East & Africa Sedation In ICU Setting Revenue by Country (2016-2026)
10.3.2 Turkey Sedation In ICU Setting Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Sedation In ICU Setting Market Size and Forecast (2016-2026)
10.3.4 UAE Sedation In ICU Setting Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Sedation In ICU Setting Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Sedation In ICU Setting Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Sedation In ICU Setting Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Sedation In ICU Setting Revenue (USD Million) by Region (2016-2021)
Table 5. Global Sedation In ICU Setting Revenue Market Share by Region (2021-2026)
Table 6. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 7. AstraZeneca Major Business
Table 8. AstraZeneca Sedation In ICU Setting Product and Solutions
Table 9. AstraZeneca Sedation In ICU Setting Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 11. GlaxoSmithKline Major Business
Table 12. GlaxoSmithKline Sedation In ICU Setting Product and Solutions
Table 13. GlaxoSmithKline Sedation In ICU Setting Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Mylan Corporate Information, Head Office, and Major Competitors
Table 15. Mylan Major Business
Table 16. Mylan Sedation In ICU Setting Product and Solutions
Table 17. Mylan Sedation In ICU Setting Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Fresenius Corporate Information, Head Office, and Major Competitors
Table 19. Fresenius Major Business
Table 20. Fresenius Sedation In ICU Setting Product and Solutions
Table 21. Fresenius Sedation In ICU Setting Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Teva Corporate Information, Head Office, and Major Competitors
Table 23. Teva Major Business
Table 24. Teva Sedation In ICU Setting Product and Solutions
Table 25. Teva Sedation In ICU Setting Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. B. Braun Holding Corporate Information, Head Office, and Major Competitors
Table 27. B. Braun Holding Major Business
Table 28. B. Braun Holding Sedation In ICU Setting Product and Solutions
Table 29. B. Braun Holding Sedation In ICU Setting Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Aspen Corporate Information, Head Office, and Major Competitors
Table 31. Aspen Major Business
Table 32. Aspen Sedation In ICU Setting Product and Solutions
Table 33. Aspen Sedation In ICU Setting Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Global Sedation In ICU Setting Revenue (USD Million) by Players (2019-2021)
Table 35. Global Sedation In ICU Setting Revenue Share by Players (2019-2021)
Table 36. Breakdown of Sedation In ICU Setting by Company Type (Tier 1, Tier 2 and Tier 3)
Table 37. Sedation In ICU Setting Players Head Office, Products and Services Provided
Table 38. Sedation In ICU Setting Mergers & Acquisitions in the Past Five Years
Table 39. Sedation In ICU Setting New Entrants and Expansion Plans
Table 40. Global Sedation In ICU Setting Revenue (USD Million) by Type (2016-2021)
Table 41. Global Sedation In ICU Setting Revenue Share by Type (2016-2021)
Table 42. Global Sedation In ICU Setting Revenue Forecast by Type (2021-2026)
Table 43. Global Sedation In ICU Setting Revenue by Application (2016-2021)
Table 44. Global Sedation In ICU Setting Revenue Forecast by Application (2021-2026)
Table 45. North America Sedation In ICU Setting Revenue by Type (2016-2021) & (USD Million)
Table 46. North America Sedation In ICU Setting Revenue by Type (2021-2026) & (USD Million)
Table 47. North America Sedation In ICU Setting Revenue by Application (2016-2021) & (USD Million)
Table 48. North America Sedation In ICU Setting Revenue by Application (2021-2026) & (USD Million)
Table 49. North America Sedation In ICU Setting Revenue by Country (2016-2021) & (USD Million)
Table 50. North America Sedation In ICU Setting Revenue by Country (2021-2026) & (USD Million)
Table 51. Europe Sedation In ICU Setting Revenue by Type (2016-2021) & (USD Million)
Table 52. Europe Sedation In ICU Setting Revenue by Type (2021-2026) & (USD Million)
Table 53. Europe Sedation In ICU Setting Revenue by Application (2016-2021) & (USD Million)
Table 54. Europe Sedation In ICU Setting Revenue by Application (2021-2026) & (USD Million)
Table 55. Europe Sedation In ICU Setting Revenue by Country (2016-2021) & (USD Million)
Table 56. Europe Sedation In ICU Setting Revenue by Country (2021-2026) & (USD Million)
Table 57. Asia-Pacific Sedation In ICU Setting Revenue by Type (2016-2021) & (USD Million)
Table 58. Asia-Pacific Sedation In ICU Setting Revenue by Type (2021-2026) & (USD Million)
Table 59. Asia-Pacific Sedation In ICU Setting Revenue by Application (2016-2021) & (USD Million)
Table 60. Asia-Pacific Sedation In ICU Setting Revenue by Application (2021-2026) & (USD Million)
Table 61. Asia-Pacific Sedation In ICU Setting Revenue by Region (2016-2021) & (USD Million)
Table 62. Asia-Pacific Sedation In ICU Setting Revenue by Region (2021-2026) & (USD Million)
Table 63. South America Sedation In ICU Setting Revenue by Type (2016-2021) & (USD Million)
Table 64. South America Sedation In ICU Setting Revenue by Type (2021-2026) & (USD Million)
Table 65. South America Sedation In ICU Setting Revenue by Application (2016-2021) & (USD Million)
Table 66. South America Sedation In ICU Setting Revenue by Application (2021-2026) & (USD Million)
Table 67. South America Sedation In ICU Setting Revenue by Country (2016-2021) & (USD Million)
Table 68. South America Sedation In ICU Setting Revenue by Country (2021-2026) & (USD Million)
Table 69. Middle East & Africa Sedation In ICU Setting Revenue by Type (2016-2021) & (USD Million)
Table 70. Middle East & Africa Sedation In ICU Setting Revenue by Type (2021-2026) & (USD Million)
Table 71. Middle East & Africa Sedation In ICU Setting Revenue by Application (2016-2021) & (USD Million)
Table 72. Middle East & Africa Sedation In ICU Setting Revenue by Application (2021-2026) & (USD Million)
Table 73. Middle East & Africa Sedation In ICU Setting Revenue by Country (2016-2021) & (USD Million)
Table 74. Middle East & Africa Sedation In ICU Setting Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Sedation In ICU Setting Picture
Figure 2. Global Sedation In ICU Setting Revenue Market Share by Type in 2020
Figure 3. Propofol
Figure 4. Dexmedetomidine
Figure 5. Remifentanil
Figure 6. Others
Figure 7. Sedation In ICU Setting Revenue Market Share by Application in 2020
Figure 8. Neonatal Intensive Care Unit Picture
Figure 9. Child Intensive Care Unit Picture
Figure 10. Adult Intensive Care Unit Picture
Figure 11. Global Sedation In ICU Setting Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Sedation In ICU Setting Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Sedation In ICU Setting Revenue Market Share by Region (2016-2026)
Figure 14. Global Sedation In ICU Setting Revenue Market Share by Region in 2020
Figure 15. North America Sedation In ICU Setting Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Sedation In ICU Setting Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Sedation In ICU Setting Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Sedation In ICU Setting Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Sedation In ICU Setting Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Sedation In ICU Setting Market Drivers
Figure 21. Sedation In ICU Setting Market Restraints
Figure 22. Sedation In ICU Setting Market Trends
Figure 23. AstraZeneca Recent Developments and Future Plans
Figure 24. GlaxoSmithKline Recent Developments and Future Plans
Figure 25. Mylan Recent Developments and Future Plans
Figure 26. Fresenius Recent Developments and Future Plans
Figure 27. Teva Recent Developments and Future Plans
Figure 28. B. Braun Holding Recent Developments and Future Plans
Figure 29. Aspen Recent Developments and Future Plans
Figure 30. Global Sedation In ICU Setting Revenue Share by Players in 2020
Figure 31. Sedation In ICU Setting Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 32. Global Top 3 Players Sedation In ICU Setting Revenue Market Share in 2020
Figure 33. Global Top 10 Players Sedation In ICU Setting Revenue Market Share in 2020
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 35. Global Sedation In ICU Setting Revenue Share by Type in 2020
Figure 36. Global Sedation In ICU Setting Market Share Forecast by Type (2021-2026)
Figure 37. Global Sedation In ICU Setting Revenue Share by Application in 2020
Figure 38. Global Sedation In ICU Setting Market Share Forecast by Application (2021-2026)
Figure 39. North America Sedation In ICU Setting Sales Market Share by Type (2016-2026)
Figure 40. North America Sedation In ICU Setting Sales Market Share by Application (2016-2026)
Figure 41. North America Sedation In ICU Setting Revenue Market Share by Country (2016-2026)
Figure 42. United States Sedation In ICU Setting Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Sedation In ICU Setting Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Sedation In ICU Setting Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Sedation In ICU Setting Sales Market Share by Type (2016-2026)
Figure 46. Europe Sedation In ICU Setting Sales Market Share by Application (2016-2026)
Figure 47. Europe Sedation In ICU Setting Revenue Market Share by Country (2016-2026)
Figure 48. Germany Sedation In ICU Setting Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Sedation In ICU Setting Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Sedation In ICU Setting Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Sedation In ICU Setting Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Sedation In ICU Setting Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Sedation In ICU Setting Sales Market Share by Type (2016-2026)
Figure 54. Asia-Pacific Sedation In ICU Setting Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Sedation In ICU Setting Revenue Market Share by Region (2016-2026)
Figure 56. China Sedation In ICU Setting Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Sedation In ICU Setting Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South Korea Sedation In ICU Setting Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Sedation In ICU Setting Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Sedation In ICU Setting Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Sedation In ICU Setting Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Sedation In ICU Setting Sales Market Share by Type (2016-2026)
Figure 63. South America Sedation In ICU Setting Sales Market Share by Application (2016-2026)
Figure 64. South America Sedation In ICU Setting Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Sedation In ICU Setting Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Sedation In ICU Setting Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East and Africa Sedation In ICU Setting Sales Market Share by Type (2016-2026)
Figure 68. Middle East and Africa Sedation In ICU Setting Sales Market Share by Application (2016-2026)
Figure 69. Middle East and Africa Sedation In ICU Setting Revenue Market Share by Country (2016-2026)
Figure 70. Turkey Sedation In ICU Setting Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Saudi Arabia Sedation In ICU Setting Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. UAE Sedation In ICU Setting Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source